These include the lower prevalence of HLA B27 in IBDSpA compared to classic AS,46–48 the relative contra-indication of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with IBD53 and the lack of specificity of elevated serum CRP, as it may be due to active intestinal inflammation, as well. The gene discussed is CRP; the disease is inflammation.